<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142856">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01819584</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-12-9794-KM-CTIL</org_study_id>
    <nct_id>NCT01819584</nct_id>
  </id_info>
  <brief_title>Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism</brief_title>
  <official_title>Long Term Glucose Metabolism in Conservatively Treated Patients With Congenital Hyperinsulinism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <authority>Israel: Israeli Health Ministry Pharmaceutical Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to continue follow up of conservatively treated CHI patients
      and to focus on their metabolic outcome, including frequency of hypoglycemia after
      discontinuing treatment and incidence of diabetes mellitus in the long term.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>presence and frequency of hypoglycemia and hyperglycemia.</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of diabetes mellitus</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>presence of metabolic syndrome</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Conservatively Treated CHI Patients</condition>
  <arm_group>
    <arm_group_label>Patients  below 15 years old</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients  above 15 years old</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study will include conservatively treated CHI patients who are in remission for at
        least one year
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  conservatively treated CHI patients who are in remission for at least one year

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 24, 2013</lastchanged_date>
  <firstreceived_date>March 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyperinsulinism</mesh_term>
    <mesh_term>Persistent Hyperinsulinemia Hypoglycemia of Infancy</mesh_term>
    <mesh_term>Nesidioblastosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
